Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
May 2018
in “
The Journal of Urology
”
Studysummary This study concluded that 5α-reductase inhibitors were associated with improved survival in men with bladder cancer, while α-blockers showed no effect.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on trepo.tuni.fi →